Centro de Investigación Cooperativa en Biotecnología-ko ikertzaileekin lankidetzan egindako argitalpenak (22)

2022

  1. PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer

    Oncogenesis, Vol. 11, Núm. 1

2021

  1. Identification of androgen receptor metabolic correlome reveals the repression of ceramide kinase by androgens

    Cancers, Vol. 13, Núm. 17

2020

  1. CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo

    Journal of Clinical Investigation, Vol. 130, Núm. 5, pp. 2435-2450

  2. Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer

    The Journal of experimental medicine, Vol. 217, Núm. 6

  3. Targeting PML in triple negative breast cancer elicits growth suppression and senescence

    Cell Death and Differentiation, Vol. 27, Núm. 4, pp. 1186-1199

2019

  1. RMTA: Robust metabolic transformation analysis

    Bioinformatics, Vol. 35, Núm. 21, pp. 4350-4355

2018

  1. Cancertool: A visualization and representation interface to exploit cancer datasets

    Cancer Research, Vol. 78, Núm. 21, pp. 6320-6328

  2. Integrative analysis of transcriptomics and clinical data uncovers the tumor-suppressive activity of MITF in prostate cancer

    Cell Death and Disease, Vol. 9, Núm. 10

  3. Low-dose statin treatment increases prostate cancer aggressiveness

    Oncotarget, Vol. 9, Núm. 2, pp. 1494-1504

  4. Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression

    Journal of Extracellular Vesicles, Vol. 7, Núm. 1

  5. Metabolism and transcription in cancer: Merging two classic tales

    Frontiers in Cell and Developmental Biology

  6. MicroRNA-506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation

    Hepatology, Vol. 67, Núm. 4, pp. 1420-1440

  7. PPARd elicits ligand-independent repression of trefoil factor family to limit prostate cancer growth

    Cancer Research, Vol. 78, Núm. 2, pp. 399-409

2017

  1. MTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

    Nature, Vol. 547, Núm. 7661, pp. 109-113

  2. Mitochondrial Metabolism: Yin and Yang for Tumor Progression

    Trends in Endocrinology and Metabolism, Vol. 28, Núm. 10, pp. 748-757

  3. New insights on prostate cancer progression

    Cell Cycle

  4. Quiescence-like Metabolism to Push Cancer Out of the Race

    Cell Metabolism

2016

  1. Stratification and therapeutic potential of PML in metastatic breast cancer

    Nature Communications, Vol. 7

  2. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis

    Nature Cell Biology, Vol. 18, Núm. 6, pp. 645-656

  3. Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer

    Oncotarget, Vol. 7, Núm. 6, pp. 6835-6846